Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications [0.03%]
用于乳腺癌治疗的定点药物递送的新型聪明靶向策略：临床潜力及应用
Pedram Ebrahimnejad,Zahra Mohammadi,Amirhossein Babaei et al.
Pedram Ebrahimnejad et al.
For more than a decade, researchers have been working to achieve new strategies and smart targeting drug delivery techniques and technologies to treat breast cancer (BC). Nanotechnology presents a hopeful strategy for targeted drug delivery...
Peggy Arthur,Anil Kumar Kalvala,Sunil Kumar Surapaneni et al.
Peggy Arthur et al.
Neuropathic pain is experienced due to injury to the nerves, underlying disease conditions or toxicity induced by chemotherapeutics. Multiple factors can contribute to neuropathic pain such as central nervous system (CNS)-related autoimmune...
A Narrative Review on Non-Invasive Drug Delivery of Teriparatide: A Ray of Hope [0.03%]
非侵入式特立帕肽给药研究的叙事综述——带来希望的一线光明
Neeraj Mittal,Gajanand Sharma,Om Parkash Katare et al.
Neeraj Mittal et al.
In the field of pharmaceutical biotechnology and formulation development, various protein and peptide-based drugs have been used for therapeutic and clinical implications. These are mainly given via parenteral routes like intravenous, subcu...
Impact of Nanotechnology on Differentiation and Augmentation of Stem Cells for Liver Therapy [0.03%]
纳米技术在干细胞分化和增强以用于肝脏治疗方面的应用影响
Ifrah Anwar,Usman Ali Ashfaq
Ifrah Anwar
The liver is one of the crucial organs of the body that performs hundreds of chemical reactions needed by the body to survive. It is also the largest gland of the body. The liver has multiple functions, including the synthesis of chemicals,...
Advances in Current Drugs and Formulations for the Management of Atopic Dermatitis [0.03%]
特应性皮炎的当前药物和制剂的研究进展
Keerthi Atluri,Srikanth Manne,Vijendra Nalamothu et al.
Keerthi Atluri et al.
Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease with a complex pathophysiology. Treatment of AD remains challenging owing to the presence of a wide spectrum of clinical phenotypes and limited response to existing th...
Recent Advances in Teriparatide Delivery by-virtue-of Novel Drug Delivery Approaches for the Management of Osteoporosis [0.03%]
新型药物输送手段促进特立帕肽治疗骨质疏松症的研究进展
Sagar Salave,Dhwani Rana,Kedar Prayag et al.
Sagar Salave et al.
Osteoporosis is a bone incapacitating malady which globally accounts for over hundred million fractures annually. Therapeutic interventions for management of osteoporosis are divided as antiresorptive agents and osteoanabolic agents. Teripa...
Venkata Deepthi Vemuri,Rekharani Kushwaha,Gollu Gowri et al.
Venkata Deepthi Vemuri et al.
Macrophages are immuno cells with high flexibility among hematopoietic system. Macrophages are tangled with many diseases like chronic inflammatory, atherosclerosis, autoimmune, and cancer. Macrophages play a major role in developing the in...
Exploring the Therapeutic Potential of Cyclosporine for Ophthalmic Indications by Novel Carrier Systems [0.03%]
新型载体系统用于探究环孢素治疗眼科疾病的潜力
Garima Rawat,Shital Kolhe,Dhwani Rana et al.
Garima Rawat et al.
Cyclosporine (CsA) stays the most intangible molecule holding a good history for treating several ophthalmic conditions and it even attributes to multiple off-label uses. Topical delivery of CsA is the most preferred route but owing to the ...
Exosomes: Recent Advances and Challenges as Targeted Therapeutic Delivery Vesicles [0.03%]
外泌体：作为靶向治疗递送载体的新进展与挑战
Sourabh Jadhav,Ankaj Kumar,Arvind Gulbake
Sourabh Jadhav
The exosome is a naturally derived nanostructured lipid vesicle that ranges from 40-100 nm in size and is utilized to transport drugs, and biological macromolecules, including therapeutic RNA and proteins. It is a membrane vesicle actively ...
Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant Prostate Cancer [0.03%]
纳米治疗在局灶性和晚期雄激素耐药性前列腺癌的化疗和基因治疗中的应用
Satish Sharma,Supriya D Mahajan,Kent Chevli et al.
Satish Sharma et al.
Treatments for late-stage prostate cancer (CaP) have not been very successful. Frequently, advanced CaP progresses to castration-resistant prostate cancer (CRPC), with 50#37;-70% of patients developing bone metastases. CaP with bone metasta...